Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
Zur Ablage hinzufügen
  Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben
Patent

Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools

MPG-Autoren
/persons/resource/persons121849

Seeberger,  Peter H.
Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121626

Martin,  Christopher E.
Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121178

Bröcker,  Felix
Chakkumal Anish, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121100

Chakkumkal,  Anish
Chakkumal Anish, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)

2156857.pdf
(Verlagsversion), 4MB

Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Seeberger, P. H., Martin, C. E., Bröcker, F., & Chakkumkal, A.(2013). Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools.


Zitierlink: https://hdl.handle.net/11858/00-001M-0000-0027-1401-0
Zusammenfassung
The invention relates to a synthetic oligosaccharide representing part of the repeating unit of the Clostridium difficile
glycopolymer PS-I and having the sequence of the pentasaccharide a-L-Rhap- ( 1---+3 ) -B-D-Glcp- ( 1---+4) - [a-L-Rhap- ( 1---+3 ] -aD-
Glcp- ( 1---+2 ) -a-D-Glcp or a synthetic fragment or derivative thereof. Preferably, the claimed synthetic oligosaccharide bears at
least one linker L for conjugation to a carrier protein or for immobilization on a surface. Further aspects of the invention relate to advantageous
methods for synthesizing said synthetic oligosaccharide and oligosaccharide-protein conjugate as well as to uses thereof,
in particular as vaccines and diagnostic tools.